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Selection of an HLA identical donor is a critical pre-requisite for successful hematopoietic stem cell transplantation
(HSCT). Most transplant centers utilize blood as the most common source of DNA for HLA testing. However, obtaining
blood through phlebotomy is often challenging in patients with conditions like severe leucopenia or hemophilia,
pediatric and elderly patients. We have used a simple in-house protocol and shown that HLA genotypes obtained on
DNA extracted from saliva or hair are concordant with blood and hence can be used for selection of donors for HSCT or
organ transplantation. Similarly, for post-HSCT chimerism monitoring, non-availability of pre-transplant DNA samples
poses a major limitation of reference STR fingerprints. This study shows that DNA obtained post-HSCT from hair follicles
can be used to generate pre-transplant patient specific fingerprints while the STR profiles obtained in saliva samples
cannot as these display a mixed state of chimerism.
Introduction
Allogeneic hematopoeitic stem cell transplantation (HSCT) is the
preferred treatment for several hematological diseases, metabolic
disorders and a variety of immunodeficiencies. The process of
HLA matching for selection of a suitable donor for HSCT is a
key step that requires low to high resolution HLA genotyping
using multiple molecular technologies and appreciable laboratory
expertise. Peripheral venous blood is the most preferred source of
DNA for such genetic testing due to high yields (~10–15 ng/mlo f
whole blood) and customary practice. However, alternates to
phlebotomy might be quite useful for the pediatric population,
as well as for patients with severe aplastic anemia (SAA) or
hemophilia.
One essential component of evaluating the success of an HSCT
outcome is the post-transplant chimerism based monitoring of
engraftment and an early detection of rejection and/or molecular
relapse. This involves STR/VNTR based analyses similar to the
DNA fingerprinting and is a highly sensitive technique that can
quantify percent donor cells up to 0.1%. The major advantage of
the technique is the ability to detect an early molecular relapse,
and thus help in instituting timely donor lymphocyte infusions
(DLI). Chimerism testing relies upon comparing fingerprints of
post-HSCT recipient with that of the donor and that of pre-
transplant patient sample every time a test is performed. However,
in practice, the pre-transplant patient-derived DNA sample is
often not available or may be insufficient for recurrent testings
at different post-HSCT time points. In such situations, alternate
sources of DNA like buccal swabs or mouthwashes have
been tried, but these are not always suitable because these
tissues get gradually replaced by donor-derived cells following
transplantation.
1
These limitations encouraged us to examine alternative sources
of DNA that could be adopted for donor recipient HLA match-
ing and/or chimerism testing. Isolation of DNA from multiple
sources including buccal epithelial cells,
2-4 mouthwashes,
5,6
formalin-fixed paraffin embedded tissues,
7 sperm cells,
8 saturated
spit wads,
9 saliva,
8,10 buccal swabs
11 and treated cards
2 have often
been tried for epidemiological studies and forensic applications.
None of these have, however, been examined extensively for
transplant related applications like HLA analysis for donor
selection or chimerism evaluation. Although saliva has been used
as a common source of DNA, limited information is available
on the suitability of DNA obtained from saliva for HLA testing,
12
or from hair for HLA class II typing,
13 there are no published
reports, to the best of our knowledge, on using such alternate
sources of DNA for donor selection for HSCT in clinical practice.
Recently, studies by Hong et al.,
14 Rovo A et al.
15 and Seifert B
et al.
16 have shown that the hair follicles are devoid of plasticity
unlike adult stem cells and that these may serve as a reliable source
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of recipient profile in the absence of pre-transplant reference
DNA during post-HSCT evaluation. More recently, however,
Jacewicz and coworkers,
17 using a relatively sensitive RQ-PCR
assay system, suggested that hair follicles are not devoid of
transdifferentiation and that these may possess cells of both
recipient as well as the donor origin. It therefore appears plausible
to examine the advantage of using hair as an alternate and useful
source of DNA for chimerism monitoring. In this study, we have
sought to investigate the suitability of two alternate sources of
DNA, saliva and hair follicles for donor-recipient HLA matching
and for chimerism monitoring in patients undergoing allogeneic
HSCT. The study showed that both these sources provide
sufficient quantity and quality of DNA suitable for HLA
genotyping for routine donor selection and may actually be
convenient resources to supplement unrelated donor search
activities. Further, for STR based chimerism monitoring, DNA
obtained from hair follicles (but not saliva) could be utilized
as a pre-transplant patient reference since hair follicles retained
their original genomic integrity following successful donor HSC
engraftment. On the contrary, saliva or mouthwashes contain a
mixture of cells including lymphocytes as well as epithelial cells
and hence are more likely to develop mixed state of chimerism
and is thus not suitable to obtain information on the pre-
transplantation genotype of the recipient.
18 These observations
are relatively debatable and remain an issue of technique
specificity and sensitivity, probable detection limits and the
levels of chimerism (or micro-chirmerism) of the donor
constituent cells.
Results
DNA preparations. A comparison of the OD 260/280 and
260/230 absorbance ratios and the yield of DNA preparations
obtained from three different sources, namely, blood, saliva and
hair follicles is shown in Table 1. The average 260/280 and
260/230 ratios of all the samples tested were corrected for
background absorbance at 320 nm and were found to be in the
range of 1.69 to 2.13 and 1.8 to 2.98 respectively, indicating
that preparations were free from protein and polysaccharide
contaminations respectively. The overall yield of DNA obtained
was comparable in all the three sources i.e., saliva (39.4–96.3 mg/
ml in healthy and 1.17–114 mg/ml in patients), peripheral blood
(9.46–57.45 mg/ml in healthy and 2.45–69.23 mg/ml in patients)
and hair (0.1–0.9 mg/6 hairs in healthy and 0.1–0.8 mg/6 hairs in
patients).
A comparison of DNA preparations electrophoresed in 0.8%
agarose gels confirmed an overall integrity, good quality and
quantity in all isolations whether prepared from peripheral blood,
hair or saliva.
HLA typing. HLA class I and class II typing was performed
using three molecular techniques viz., PCR-SSP, reverse line strip
hybridization (RLS) and reverse SSO by Luminex. A representa-
tive PCR-SSP gel image for HLA-A typing using blood, saliva and
hair simultaneously in one of the individuals is shown in Figure1.
Similar typing results were obtained by RLS hybridization, and
reverse SSO techniques. All the three DNA sources tested, i.e.,
peripheral blood, saliva and hair follicles gave absolutely consistent
HLA typing results in each individual and irrespective of the
original source of DNA utilized (data not shown).
Chimerism monitoring. Well resolved STR based chimerism
profiles were obtained with all the patient DNA samples tested
and these were not affected whether isolated from hair (Fig.2)
or saliva (Fig.3) or peripheral blood (Figs.2 and 3). Gene
Mapper analysis showed sharp STR allele specific peaks and there
were no stutters or nonspecific amplifications in all the tests
performed.
Hair-derived DNA retain pre-HSCT recipient fingerprints. An
example of the hair-derived STR profile corresponding to FES
marker and its comparison with blood-derived profile in a patient
with Thalassemia major at d +153 post-HSCT is shown in
Figure2. The STR profile seen in recipient’s blood post-
transplant was completely the same as the donor (allele peaks
220 and 224 bp) (Fig.2C and D). This is in contrast to the
profile obtained in the hair sample (216 and 220 bp peaks)
(Fig.2B) which showed similarity to the original pre-recipient
blood reference profile (Fig.2A) instead of the donor (Fig.2C).
Similar observations were made in all other patients suggesting
that hair, unlike saliva, retained the original patient profile and
could be utilized as a pre-transplant reference for chimerism
studies employing STR based Genescan analyses on automated
DNA sequencer.
Saliva-derived DNA exhibit mixed chimerism fingerprints.
Figure3 illustrates an example of chimerism profile obtained in
a CML patient at d +1861 post-HSCT with 100% donor
chimerism in peripheral blood (Fig.3C). A saliva sample was
collected from this patient and processed in parallel with the
blood and was found to possess peaks corresponding to both
patient (222 + 232 bp) and donor (226 + 232 bp) specific profiles
(Fig.3D). As expected, the saliva being composed of lymphocytes
as well as epithelial and other cell types, displayed a mixed profile
of pre- and post-transplant STR fingerprints. Hence, the saliva-
derived DNA may be utilized for HLA typing purposes but
cannot substitute for a pre-recipient DNA reference sample for
chimerism analysis.
Simultaneous analyses of post-transplant blood, hair and saliva
fingerprints. In this study, 18 patients out of 24 had 100% donor
chimerism while six patients had mixed chimerism based on
blood-derived fingerprints at various time points ranging from
d + 55 to d + 1855 post-transplant as shown in Table 1. All these
patients were tested for the status of chimerism in their hair,
saliva and blood samples simultaneously and the results obtained
are summarized in Figure4.
As shown in Figure4A, complete donor chimerism was
observed in blood samples in 18 patients at different time points
post-transplant. In analogy, the hair-derived profiles did not
show any donor contribution in these patients and remained at 0
baseline. The saliva-derived fingerprints displayed mixed chime-
rism ranging from 10% to 88.7% maximum. Careful analysis of
saliva STR profiles revealed a trend where the mixed chimerism
profile showed a gradual skewing toward higher donor type at
the later post-HSCT time points as compared with early post-
HSCT period, though in different patients.
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In patients with mixed chimerism prevailing in blood (Fig.4B),
a mixed profile was also seen in their saliva samples. However, the
relative percentage of the donor chimerism was relatively lesser in
the DNA obtained from saliva than that of the blood in all the
patients except one on d + 4140 where it was marginally greater in
saliva-derived DNA than that of blood (Fig.4B and Table 1).
Discussion
The main impetus for this study came from difficulties
encountered frequently with peripheral blood sample collection
in a variety of situations particularly when dealing with patients
with low total leukocyte counts. This often led to inadvertent
delays in histocompatibility testing and complications in post-
HSCT monitoring of engraftment. Major practical difficulties
encountered include collecting enough DNA from patients with
Severe Aplastic Anemia who have leucopenia or the pediatric
group of patients for HLA matching purposes. Often, it is
necessary to store additional aliquots of DNA to be used as a pre-
transplant reference during post-HSCT chimerism monitoring
and is not possible in such patients. Hence, we opted to
investigate the suitability of alternative DNA sources for the above
tests in these patients rather than waiting for them to recover their
total leukocyte counts (TLCs) in the peripheral blood. The idea
was to avoid the unwarranted delays that the latter could cause in
reporting HLA typing results and subsequently the HSCT.
The study enrolled 30 volunteers, 24 of whom were patients
who underwent allogeneic sibling HSCT while six were healthy
individuals. Samples were collected for DNA extraction from
three different sources, i.e., blood, saliva and hair in these subjects.
The DNA preparations from all the three sources (blood, hair and
saliva) were found to be relatively pure, of good quality and intact
as confirmed both spectrophotometrically as well as by agarose gel
electrophoresis. Consistent HLA typing results were obtained
using SSP, rSSO and SBT (data not shown) from all three sources
despite the fact that saliva harbors a substantial proportion of
microbes and may be contaminated with RNA. These observa-
tions are in agreement with the findings of other studies.
12,19
Further, the protocol described is relatively cost effective as it
excludes costs incurred on phlebotomy or procurement of
commercial kits available for DNA isolation.
This approach of using saliva and hair follicles as alternates to
phlebotomy has several advantages: (1) ideal for pediatric or
elderly patients, (2) quick, easy and non-invasive, (3) excludes
requirements of a trained phlebotomist, precludes trauma caused
by needle pricks, (4) best suited for patients with leucopenia
(SAA) or hemophiliacs, (5) offers an easy option to establish
saliva/hair banks to supplement unrelated marrow donor registries
particularly in low-resource settings, (6) is suitable for material
transfer and storage and (7) adaptable to other genetic testing set-ups.
Saliva as a fine and acceptable source of human genomic
DNA
19,20 is now well established. Our results indicate that it can
Figure1. An agarose gel (2%) showing representative SSP based typing of HLA-A alleles using DNA samples isolated from (A) peripheral blood, (B) saliva
and (C) hair in the same individual.
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easily be adapted for HLA typing, particularly for SAA patients
having low TLCs as well as pediatric patients. It is thus a useful
and equally effective source of DNA, offering the added advant-
ages of being economical, simple in collection and non-invasive,
lowering the risk of infections to subjects and laboratory
personnel. One of the recent applications of saliva-derived clinical
genetics is testing for presence of HLA-B*57:01 corresponding to
abacavir hypersensitivity in HIV positive individuals.
21 This
approach is not only simple but also precludes the risk of infec-
tion among the laboratory personnel. Using saliva as a source of
DNA has important relevance in genetic testing procedures since
it requires minimum infrastructure for storage, transport and can
be easily collected in fields and clinics. Establishing saliva (or hair
follicle) banks would be most economical in low-resource settings
and could prove of great advantage in supplementing HLA testing
for unrelated marrow registries for selection of HLA matched
donors.
Saliva contains about 8 million cells/ml, including approxi-
mately 1 million cells/ml of leukocytes. Epithelial cells comprise
a major portion of cells in saliva. While saliva leukocytes
post-HSCT most likely originate from donor HSCs, most
epithelial cells are of recipient origin.
18 This explains largely
why mixed chimerism was observed in saliva-derived DNA
samples despite it being 100% donor type in blood. Further, the
study showed levels of donor chimerism were relatively lower in
saliva than blood and appeared to increase progressively during
later time periods. Although these observations were made in
different patients, it is plausible that the overall salivary cellular
constituency with donor genotype emerges more gradually and
slowly in kinetics than in peripheral blood. The only patient who
showed a marginally greater mixed chimerism in saliva than in
blood was later found to be undergoing relapse after having
maintained complete donor chimerism for . 11 years. This
suggests that on one hand, cells with donor genotypes appear late
in the buccal cavity lining, on the other hand, in the case of
disease relapse following complete engraftment, these tend to lose
the donor genotypes also at a slower rate than that in the blood.
However, future studies would be needed to prove this hypothe-
sis. Recently, it has been suggested that after allo HSCT, donor
cells undergoing apoptosis release donor DNA packaged apoptotic
Figure2. Hair-derived DNA retain pre-HSCT recipient fingerprints. A comparison of representative STR marker FES resolved on ABI 3130xl automated
DNA analyzer using Genemapper software. Panels (A–D) show DNA fingerprint profiles monitored for a Thalassemia major patient on d + 153 post-HSCT.
Panel (A) shows recipient’s pre-transplant blood fingerprint (B) fingerprints on DNA obtained from post-transplant recipient’s hair, (C) shows donor’s
blood-derived fingerprint and (D) shows the profile obtained from recipient’s blood post-HSCT. Note the fingerprint of patient’s hair post-transplant
(B) remains the same as pre-transplant recipient (A) rather than of donor (C).
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bodies that are engulfed by the host epithelium and the donor-
derived genome is integrated inside nuclei of host epithelium via
horizontal DNA transfer hence leading to epithelial chimerism
and related genomic instabilities.
22 The exact mechanisms
underlying emergence of host epithelial cells with donor genotype
are unclear and remain divergent.
Nonetheless, the present study indicates that while saliva-
derived DNA offers a useful alternative for donor-recipient HLA
matching, this source cannot be used as a reference of the original
recipient profile for post-transplant monitoring of chimerism.
Similar observations have been made by others.
14-16 The theories
explaining this phenomenon range from homing of bone marrow
cells to the injured salivary glands
20 to trans-differentiation of
hematopoietic stem cells
23 and the presence of associated hemato-
poietic and non-hematopoietic mesenchymal, endothelial pro-
genitors within the transplanted marrow. Salivary proteome
alterations have been reported following allogeneic stem cell
transplantation independent of the type of pre-conditioning
regimens.
24 These data suggest that changes due to plasticity of
hematopoietic donor stem cells or their horizontal DNA transfer
like mechanisms can be observed frequently in saliva. Our results
support these observations and conclude that saliva cannot
substitute for pre-transplant recipient genetic profiling for
chimerism testing.
As opposed to saliva, the DNA obtained from hair was found
to retain the original recipient genetic integrity even after post-
HSCT owing to the suspected lack of plasticity or other unknown
mechanisms. Similar observations have been made earlier by
Hong and coworkers
14 while others failed to confirm this.
17 The
former studies utilized STR analyses and showed that hair lacks
plasticity. The latter study, however, used highly sensitive
Y-chromosome specific STRs and RQ-PCR with the sex-
determining region Y (SRY) based TaqMan florescent assays
and showed that the donor-specific DNA could be found in
recipient’s hair follicles though at very minimal levels. Under-
standing the underlying molecular mechanisms and verifying
whether hair transdifferentiation occurs or not is currently beyond
the scope of this study. Nevertheless, our results provide evidence
that DNA extracted from hair follicles could be used successfully
not only for donor selection but also for chimerism monitoring
and as a reliable substitute for pre-transplant DNA sample when
routinely utilized STR based fragment analyses protocols are
adapted. Taken together, both saliva and hair appear to be
excellent sources of DNA that can be used to advantage in clinical
Figure3. Saliva-derived DNA STR fingerprints display mixed chimerism. A comparison of representative STR marker D21S11 resolved on ABI 3130xl
automated DNA analyzer using Genemapper software. Panels (A–D) show DNA fingerprint profiles monitored for a CML patient on d + 1861 post-HSCT.
Panel (A) shows recipient’s pre-transplant blood fingerprint (B) shows donor’s blood fingerprint, (C and D) show the profiles obtained from recipient’s
blood and saliva respectively on post-HSCT d + 1861 respectively. Note the presence of both donor- and patient-derived mixed chimerism peaks in
(D) corresponding to saliva sample.
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settings for hematopoietic stem cell transplantation and particularly
f o rs i t u a t i o n si n v o l v i n gp e d i a t r i cp a t i e n t so rt h o s ew i t hl e u c o p e n i a .
Materials and Methods
Subjects. The study was performed on six healthy volunteers
and 24 patients [6 chronic myeloid leukemia (CML), 3 acute
lyphoid leukemia (ALL), 3 acute myeloid leukemia (AML),
9 severe aplastic anemia (SAA) and 3 thalassemia major] who
underwent allogeneic sibling donor HSCT at the All India
Institute of Medical Sciences, New Delhi (Table 1). The study
volunteers were enrolled after their informed consent and as per
the ethical guidelines for human experimentation laid down by
the ethics committee of the All India Institute of Medical
Sciences, New Delhi.
The patients were tested for chimerism at various time points
post-transplant using a panel of STR/ VNTR markers as described
in the following sections.
Collection of samples. Peripheral blood. Approximately 5 ml
of blood was collected by venipuncture in K2-EDTA tubes and
mixed properly to avoid coagulation.
Saliva. Samples of saliva were collected from subjects after an
hour of brushing their teeth (avoiding eating, drinking or smoking
in the duration). After having rinsed their mouths briefly, 2 ml
saliva was expelled into 50 ml sterile conical centrifuge tubes.
Hair. Six strands of hair with attached follicles/bulbs (deter-
mined by visual confirmation) were plucked from different areas
of scalp of the subjects. The extra shaft regions of the hair were
cleaved and the hair bulbs (~0.5 cm) were collected in a 2 ml
Eppendorf tube containing 1 ml 1X PBS. The follicles were
rinsed and washed carefully to remove any contaminating blood
cells before processing for DNA extraction.
Extraction of DNA from blood. The genomic DNA was
extracted from peripheral blood by the modified salting out
method;
25 5 ml of whole blood was mixed with 45 ml red cell
lysis buffer (RCLB) (0.14 M ammonium chloride, 1 mM sodium
Figure4. Relative donor chimerism (% DC) observed post-HSCT in saliva and hair in patients with (A) complete 100% DC and (B) in patients displaying
mixed DC in blood.
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bicarbonate) and incubated for 20 min at room temperature.
Following centrifugation at 2,000 rpm (900 g), the nuclear pellet
was resuspended in 3 ml of nucleus buffer (0.4 M NaCl, 2 mM
Na2EDTA, 10 mM TRIS-HCl, pH 8, and 0.4% SDS) and
subjected to proteinase K (50 mg/ml) digestion at 42°C for 3–6h .
Proteins were precipitated by addition of 4 ml of 4 M ammonium
acetate and removed by centrifugation at 3,000 rpm (2,000 g) for
30 min. The supernatant was extracted with chloroform and
the DNA was precipitated with isopropanol. It was quantified
spectrophotometrically, subjected to quality evaluation and
processed for HLA typing.
Extraction of DNA from saliva. A slightly modified salting
out procedure was used for isolation of DNA from saliva as
described. The saliva sample was diluted with three volumes of
PBS and vortexed for 3–5 sec. The tubes were centrifuged at
6,000 rpm in a microfuge for 5 min to pellet out nucleated cells.
To this, 700 mL TNES (0.01 M Tris, 0.01 M Na2EDTA, 0.1 M
NaCl, 2% SDS) and 50 mg/ml Proteinase K were added. The
tubes were then incubated at 50°C overnight. After incubation,
500 mL (8 M ammonium acetate + 1 mM EDTA) and 500 mL
chloroform were added and vortexed. The mix was microfuged
at 10,000 rpm for 10 min to ensure separation of DNA and
proteins into two distinct layers. The upper aqueous phase
(containing the DNA) was transferred into a clean and sterile
2 ml Eppendorf tube containing 540 mL of isopropanol. The
solutions were mixed gently by inverting the tubes gently and
centrifuged at 10,000 rpm in a microfuge for 1 min so as to
pellet the DNA. The supernatant was drained off and 2 ml of
70% ethanol was added and the tubes inverted several times
to wash the DNA off from any remaining salts or contaminants.
The pellet was air-dried of excess ethanol and re-suspended in
100 ml TE buffer (10 mM TRIS-HCl; 1 mM EDTA; pH 7.3).
Extraction of DNA from hair. The protocol used for extrac-
tion of DNA from hair was similar to the one used for blood.
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Six hair follicles were suspended in 450 ml RCLB for 20 min and
microfuged at 8,000 rpm for 3 min. The pellet was washed again
with 450 ml RCLB. It was finally resuspended in 300 ml of NLB
followed by 20 ml 10% SDS and 10 ml proteinase K (10 mg/ml).
The mix was incubated at 60°C for 3 h or at 37°C overnight.
After incubation, 400 ml of ammonium acetate and 200 ml
chloroform were added and vortexed. The tube was microfuged
at 10,000 rpm for 10 min and the top aqueous phase of the
supernatant was transferred to a new tube. The DNA in this
aqueous phase was precipitated by adding 200 ml isopropanol,
washed with 70% ethanol twice by centrifugation before
dissolving in 20 ml TE buffer.
Evaluation of DNA quality. The DNA concentration and
purity were assessed by measuring OD using a NanoDrop
spectrophotometer (ND1000) at 230, 260, 280 and 320 nm
(Table 1). The concentration was adjusted to the desired con-
centration by adding TE buffer. The DNA preparations were
also assessed for their quality and integrity in 0.8% agarose gels.
HLA class I and class II typing for selection of donors.
HLA class I (HLA-A, B) and class II alleles (HLA-DRB1,
DRB3, DRB4, DRB5) were tested using different test procedures
of commercially available Reverse Line Strip (RLS) hybridiza-
tion (Invitrogen), PCR-SSP (BAG Healthcare GmbH/INNO-
TRAIN Diagnostik GmbH/One Lambda Inc./Invitrogen) and
reverse SSO by luminex (One Lambda Inc.) kits as per the
manufacturer’s instructions and basic guidelines as recom-
mended by the 13th International Histocompatibility Workshop
(13IHWC).
Chimerism-based monitoring of engraftment. DNA samples
collected at pre- and post-transplant time points were amplified
using customized primers for nine autosomal microsatellite loci,
namely D19S253, D18S51, THO1, D8S1179, FES, D21S11,
D3S3045, D16S5539 and D17S1290 as shown in Table 2.
These repetitive markers were selected on the basis of their
high informative indices standardized in our laboratory. The
PCR reactions were set up in the presence of 2 mM MgCl2,
200 mM dNTPs, 0.2 mM of each primer, 5 ng/ml DNA and
0.5 U/ml Taq DNA polymerase enzyme. A touchdown PCR
cycling program was followed for amplification. It included 20
initial cycles of 94°C for 15 sec, 65°C for 30 sec touchdown with
0.5°C decrease at each step, followed by 20 cycles at 94°C for
15 sec, 55°C for 30 sec, 72°C for 30 sec, followed by a thermal
delay at 72°C for 15 min.
The DNA samples were also simultaneously genotyped using
AmpFlSTR
1 Identifiler amplification kit (Applied Biosystems)
that amplifies 15 repeat markers, and examined in ABI 3130 l
Table2. Primer sequences used for STR based chimerism monitoring
Marker 5’ primer 3’ primer I-index (%)
D19S253 5’- (Fam) at aga cag aca gac gga ctg –3’ 5’- ggg agt gga gat tac ccc t –3’ 52
D18S51 5’- (Fam)ca aac ccg act acc agc aac –3’ 5’- gag cca tgt tca tgc cac tg –3’ 33
THO1 5’- gtg att ccc att ggc ctg ttc ctc –3’ 5’- (Fam)gt ggg ctg aaa agc tcc cga tta t –3’ 45
D8S1179 5’- (Fam)tt ttt gta ttt cat gtg tac att cg –3’ 5’- cgt agc tat aat tag ttc att ttc –3’ 39
FES 5’- ggg att tcc cta tgg att gg –3’ 5’- (Fam)gc gaa aga atg aga cta cat –3’ 42
D21S11 5’- gtt gta tta gtc aat gtt ctc c –3’ 5’- (Fam)gt gag tca att ccc caa g –3’ 33
D3S3045 5’-acc aaa tga gac agt ggc at-3’ 5’- (Fam)atg agg acg gtt gac atc tg-3’ 63
D16S5539 5’-gat ccc aag ctc ttc ctc tt-3’ 5’-(Fam)acg ttt gtg tgt gca tct gt-3’ 51
D17S1290 5’-gcc aac aga gca aga ctg tc-3’ 5’-(Fam)cga aac agt taa atg gcc aa-3’ 33
I-index (%) refers to informative index and indicates percent patient-donor pairs that possessed different fingerprints for the marker tested.
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sequencer following user instructions. The thermal cycling
conditions included 20 initial cycles of 94°C for 15 sec, 65°C
for 30 sec followed by 20 cycles at 94°C for 15 sec, 55°C for
30 sec, 72°C for 30 sec followed by a thermal delay at 72°C for
40 min. Amplified fragment analysis was performed using Gene
Mapper
1 Software Version 4 (Applied Biosystems) and results
documented as percent donor chimerism using mathematical
calculations as suggested.
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